Invention Grant
- Patent Title: CS1 targeted chimeric antigen receptor-modified T cells
-
Application No.: US15533153Application Date: 2015-12-07
-
Publication No.: US10821161B2Publication Date: 2020-11-03
- Inventor: Xiuli Wang , Stephen J. Forman
- Applicant: City of Hope
- Applicant Address: US CA Duarte
- Assignee: City of Hope
- Current Assignee: City of Hope
- Current Assignee Address: US CA Duarte
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2015/064303 WO 20151207
- International Announcement: WO2016/090369 WO 20160609
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; C07K16/28 ; A61P35/00 ; C07K14/71 ; C07K14/705 ; A61K39/00 ; C07K14/35 ; A61K35/17 ; C07K14/725
Abstract:
Chimeric antigen receptors for use in treating malignant melanoma and other cancers expressing CS1 are described.
Public/Granted literature
- US20170360910A1 CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS Public/Granted day:2017-12-21
Information query
